Clinical trial
Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer
NCT00293371
Study timeline
Study start (unknown)2005-02-01Date precision: month
Registry last updated2012-10-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
docetaxelDRUG · verified · RxNorm: docetaxel
prednisoneDRUG · verified · RxNorm: prednisone
vatalanibDRUG
Sponsors & collaborators
University of California, San Franciscolead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00293371 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.